Literature DB >> 10449934

Three-dimensional reconstruction of blood vessels from in vivo color Doppler optical coherence tomography images.

J Kehlet Barton1, J A Izatt, M D Kulkarni, S Yazdanfar, A J Welch.   

Abstract

PURPOSE: Current laser treatment for vascular disorders such as port wine stains can have incomplete or unacceptable results. A customized treatment strategy based on knowledge of the patient's blood vessel structure may effect an improved clinical outcome. PROCEDURE: We tested the feasibility of using color Doppler optical coherence tomography (OCT) and image processing techniques to locate, measure and reconstruct cutaneous blood vessels in rat and hamster skin. OCT is a recent, potentially noninvasive technique for imaging subsurface tissue structures with micrometer scale resolution.
RESULTS: Blood vessels were identified in a series of cross-sectional images, then a three-dimensional reconstruction was made. Parameters that can affect optimum laser treatment parameters, such as average blood vessel depth and luminal diameter, were found from the images.
CONCLUSION: This study shows that color Doppler OCT is a potential tool for improving laser treatment of vascular disorders.

Entities:  

Mesh:

Year:  1999        PMID: 10449934     DOI: 10.1159/000018148

Source DB:  PubMed          Journal:  Dermatology        ISSN: 1018-8665            Impact factor:   5.366


  10 in total

Review 1.  [Optical coherence tomography].

Authors:  J Welzel
Journal:  Hautarzt       Date:  2010-05       Impact factor: 0.751

2.  Phase-resolved optical frequency domain imaging.

Authors:  B Vakoc; S Yun; J de Boer; G Tearney; B Bouma
Journal:  Opt Express       Date:  2005-07-11       Impact factor: 3.894

3.  Enhanced detection of early-stage oral cancer in vivo by optical coherence tomography using multimodal delivery of gold nanoparticles.

Authors:  Chang Soo Kim; Petra Wilder-Smith; Yeh-Chan Ahn; Lih-Huei L Liaw; Zhongping Chen; Young Jik Kwon
Journal:  J Biomed Opt       Date:  2009 May-Jun       Impact factor: 3.170

4.  Multi-wavelength, en-face photoacoustic microscopy and optical coherence tomography imaging for early and selective detection of laser induced retinal vein occlusion.

Authors:  Van Phuc Nguyen; Yanxiu Li; Wei Zhang; Xueding Wang; Yannis M Paulus
Journal:  Biomed Opt Express       Date:  2018-11-02       Impact factor: 3.732

5.  Removing Subcutaneous Microvessels Using Photo-Mediated Ultrasound Therapy.

Authors:  Mingyang Wang; Yu Qin; Tao Wang; Jeffrey S Orringer; Yannis M Paulus; Xinmai Yang; Xueding Wang
Journal:  Lasers Surg Med       Date:  2020-05-11       Impact factor: 4.025

6.  In vivo, label-free, three-dimensional quantitative imaging of kidney microcirculation using Doppler optical coherence tomography.

Authors:  Jeremiah Wierwille; Peter M Andrews; Maristela L Onozato; James Jiang; Alex Cable; Yu Chen
Journal:  Lab Invest       Date:  2011-08-01       Impact factor: 5.662

7.  Applications of a new In vivo tumor spheroid based shell-less chorioallantoic membrane 3-D model in bioengineering research.

Authors:  Nzola De Magalhães; Lih-Huei L Liaw; Michael Berns; Vittorio Cristini; Zhongping Chen; Dwayne Stupack; John Lowengrub
Journal:  J Biomed Sci Eng       Date:  2010-01-01

8.  Statistical properties of phase-decorrelation in phase-resolved Doppler optical coherence tomography.

Authors:  Benjamin J Vakoc; Guillermo J Tearney; Brett E Bouma
Journal:  IEEE Trans Med Imaging       Date:  2009-01-19       Impact factor: 10.048

Review 9.  Optical coherence tomography of the preterm eye: from retinopathy of prematurity to brain development.

Authors:  Adam L Rothman; Shwetha Mangalesh; Xi Chen; Cynthia A Toth
Journal:  Eye Brain       Date:  2016-05-27

10.  Contrast Agent Enhanced Multimodal Photoacoustic Microscopy and Optical Coherence Tomography for Imaging of Rabbit Choroidal and Retinal Vessels in vivo.

Authors:  Van Phuc Nguyen; Yanxiu Li; Wei Qian; Bing Liu; Chao Tian; Wei Zhang; Ziyi Huang; Arjun Ponduri; Madison Tarnowski; Xueding Wang; Yannis M Paulus
Journal:  Sci Rep       Date:  2019-04-11       Impact factor: 4.379

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.